From October 1, 2022 to October 25, 2022, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 36,138,098 shares, representing 1.94% for CNY 425.67 million under the buyback announced on April 26, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.35 CNY | +1.71% | +3.34% | +19.12% |
Apr. 29 | Jointown Pharma's Q1 Profit, Revenue Fall 4% | MT |
Apr. 29 | Jointown Pharmaceutical Group's 2023 Profit Jumps 4% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.12% | 4.41B | |
+15.21% | 70.09B | |
-2.19% | 24.01B | |
+8.13% | 8.32B | |
-18.28% | 8.23B | |
0.00% | 8.08B | |
0.00% | 4.12B | |
-2.89% | 3.88B | |
+23.97% | 3.71B | |
+8.07% | 3.39B |
- Stock Market
- Equities
- 600998 Stock
- News Jointown Pharmaceutical Group Co., Ltd
- Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.